I am in a similar situation but also have the female change of life affecting weight loss attempts.Hi Everyone,
New member!
After months of badgering the hospital, GP and diabetic nurse they have finally relented and agreed it’s ok for me to go on Mounjaro albeit privately. Whilst this is less than ideal, I think the benefits far outway the cost
I’m interested in anyone who has been on this journey and how it affected you especially with background insulin and carb ratios. I’m thinking I might just cut the background and bolus insulin amounts by 50% but was hoping for some perspective rather than just guessing. Whilst I know everyone is different, I’d be really interested in any thoughts
By way of background, I’ve been a T1 diabetic for 39 years and am well controlled with my last HBA1C of 44. My current BMI is 38 which I think is a factor of insulin resistance, due to weight and pangs of hunger do to insulin volumes. I’m currently on Triseba and Fiasp if that makes any difference
My ideal is to go on the omnipod but being well controlled alongside my insulin doses, this isn’t an option
Appreciate your thoughts
Even the lowest region, London, is still prescribing 10,000 MJ pens in August but the sharp decline is noticeable at the end of a quite rapid rise.You may find this site useful to see current practice among GPs. https://openprescribing.net/analyse...ZBB&denom=total_list_size&selectedTab=summary
It does allow you to select area and even drill down to individual GP practices.
It is very interesting to see how much individual practices vary within a region.
Openprescribing does provide this analysis.
As an example, I provide the results for my own region. Corrected for the different list sizes, it gives the amount of weight loss drugs prescribed per 1000 patients so is a valid comparison. It shows variation from Zero to over 12 units per 1,000 patients in Oct.
Unfortunately it does not allow any distinction between T1D and T2D but while these figures are for all weight loss drugs, the vast majority are Mounjaro.
Also very interesting is the amounts prescribed over time. A very strong increase up to latest date Oct’25.
All of these practices refer to a limited number of specialists so the variation would seem to be due to individual doctors rather than the specialist teams. Different interpretations of national guidance perhaps but it would seem well worth having discussions with our specialists and asking for recommendations to be given to our doctors.
Try looking at your own regional and local usage …
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?